Danny Yeung Sheng-wu, a San Francisco native who is now an investor in and chief executive officer of a Hong Kong biotech firm. Photo: May Tse Danny Yeung Sheng-wu, a San Francisco native who is now an investor in and chief executive officer of a Hong Kong biotech firm. Photo: May Tse
Danny Yeung Sheng-wu, a San Francisco native who is now an investor in and chief executive officer of a Hong Kong biotech firm. Photo: May Tse
Cathy Holcombe
Opinion

Opinion

The View by Cathy Holcombe

Hong Kong investor Danny Yeung dives into biotech after trying out mango shakes and retail shop bought out by Groupon

Danny Yeung Sheng-wu, a San Francisco native who is now an investor in and chief executive officer of a Hong Kong biotech firm. Photo: May Tse Danny Yeung Sheng-wu, a San Francisco native who is now an investor in and chief executive officer of a Hong Kong biotech firm. Photo: May Tse
Danny Yeung Sheng-wu, a San Francisco native who is now an investor in and chief executive officer of a Hong Kong biotech firm. Photo: May Tse
READ FULL ARTICLE